Gapicomine

This classification denotes a vasodilating agent with the molecular formula C12H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WWW0P95393, chemically known as 4,4-(iminodimethylene)dipyridine but generally known as gapicomine, which bears US NIH Compound Identifier 68955. European Medicines Agency schedules Gapicomine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07884MIG. The term GAPICOMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). GAPICOMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gapicomine under HS 29333999 and SITC 51574. As of Q4 2014, GAPICOMINE remains the US FDA Preferred Term for this commodity. Gapicomine bears US NLM identifiers UMLS ID C1565778 and NCI Concept Code C72117. SMILES: C1=CN=CC=C1CNCC2=CC=NC=C2.